DOAC does not prevent cognitive decline in adults with AF and a low risk of stroke
Léna Rivard, MD
Acoramidis reduces all-cause mortality in ATTR-CM
Daniel Judge, MD
Audit and feedback strategy for pharmacists improves HF care
Alexander Sandhu, MD
Effect of decision support system on early optimization of lipid-lowering therapy
Kausik Ray, MBChB, MD, MPhil
Pulmonary Hypertension in COPD: Insights into Diagnosis and Treatment
Arun Jose, MD
How Artificial Sweeteners Could Be Linked to Heart Disease
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Wilson Tang, MD
Allergic Reactions and Cardiac Concerns: Exploring the Heart Disease Link
Javed Butler, MD
Jeffrey Wilson, MD
Active Aging: Preventing Heart Failure in Older Women with Exercise
Michael J. LaMonte, PhD, MPH
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Gates B. Colbert, MD
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
AHA Identifies CKM Syndrome: A First Step in Managing Patients with CVD
Chiadi Ndumele, M.D., Ph.D., M.H.S.
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Pharmacist-Prescribing and Hypertension Management: An Economic Benefit
Dave L. Dixon, PharmD, FACC, FCCP, FNLA, BCPS, BCACP, CDE, CLS
Improving Symptoms, Function, and Weight Loss in HFpEF Patients with Obesity
A Discussion on Statins to Lower CVD Risk for HIV Patients
Steve Grinspoon, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.